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Background: Optic nerve damage initiates a series of early atrophic events in retinal ganglion cells (RGCs) that
precede the BAX-dependent committed step of the intrinsic apoptotic program. Nuclear atrophy, including global
histone deacetylation, heterochromatin formation, shrinkage and collapse of nuclear structure, and the silencing of
normal gene expression, comprise an important obstacle to overcome in therapeutic approaches to preserve
neuronal function. Several studies have implicated histone deacetylases (HDACs) in the early stages of neuronal cell
death, including RGCs. Importantly, these neurons exhibit nuclear translocation of HDAC3 shortly after optic nerve
damage. Additionally, HDAC3 activity has been reported to be selectively toxic to neurons.
Results: RGC-specific conditional knockout of Hdac3 was achieved by transducing the RGCs of Hdac3fl/fl mice with
an adeno-associated virus serotype 2 carrying CRE recombinase and GFP (AAV2-Cre/GFP). Controls included similar
viral transduction of Rosa26fl/fl reporter mice. Optic nerve crush (ONC) was then performed on eyes. The ablation of
Hdac3 in RGCs resulted in significant amelioration of characteristics of ONC-induced nuclear atrophy such as H4
deacetylation, heterochromatin formation, and the loss of nuclear structure. RGC death was also significantly
reduced. Interestingly, loss of Hdac3 expression did not lead to protection against RGC-specific gene silencing after
ONC, although this effect was achieved using the broad spectrum inhibitor, Trichostatin A.
Conclusion: Although other HDACs may be responsible for gene expression changes in RGCs, our results indicate a
critical role for HDAC3 in nuclear atrophy in RGC apoptosis following axonal injury. This study provides a framework
for studying the roles of other prevalent retinal HDACs in neuronal death as a result of axonal injury.
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Glaucoma is a leading cause of blindness worldwide and
is characterized by damage to the optic nerve [1,2]. In-
creased intraocular pressure results in an increase in the
strain surrounding the optic nerve head [3,4], which is
believed to precipitate focal damage to retinal ganglion
cell (RGC) axons as they pass into the optic nerve [5].
Axogenic neurodegeneration precedes somatogenic neu-
rodegeneration in the predicted pathophysiology of a
majority of optic neuropathies, such as glaucoma [6].* Correspondence: nickells@wisc.edu
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unless otherwise stated.Optic nerve crush (ONC) mimics these molecular events
by inducing partial RGC axonal damage [7], and it is a
widely accepted model of acute RGC injury that has
been used to study intrinsic and extrinsic apoptotic
mechanisms of RGC death [7-12].
The intrinsic mechanism of apoptosis involves activa-
tion and translocation of the pro-apoptotic protein BAX
to the mitochondria following cellular injury. Oligo-
merization of BAX at the mitochondrial outer membrane
releases cytochrome c from the mitochondria [13], which
leads to activation of caspases and subsequent cell death
[14]. The steps involving BAX mark the committed step
of intrinsic apoptosis [15]. In a previous study, Bax-
deficient RGCs remained viable up to at least 72 weeksl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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stages of atrophy typical of wild type cells undergoing cell
death [8]. This was particularly evident in structural and
functional changes in RGC nuclei. The RGC nuclei were
found to exhibit atrophic characteristics including nuclear
shrinkage, histone H4 deacetylation, heterochromatin
formation, and RGC-specific gene silencing soon after
ONC [8,10,16].
Changes in the transcriptional profile of damaged neu-
rons have been described in several models of neurode-
generation, including the down regulation (silencing) of
normal gene expression and the increase in expression
of stress-response and pro-apoptotic genes [10,17-26].
Transcriptional downregulation and initiation of the
cell death mechanism in several cases of neuronal in-
jury, including RGC death, were linked with epigenetic
processes such as histone deacetylase (HDAC) activity
[10,18,19,27-29]. Although most HDACs are found ubi-
quitously in tissues, class I HDAC isoforms 1, 2, 3, and 6
are found primarily in the cells of the inner nuclear layer
and the ganglion cell layer (GCL) of the murine retina
[10,30]. A previous study showed that RGC gene silen-
cing and RGC death were attenuated following ONC as
a result of pretreatment with the broad spectrum HDAC
inhibitor Trichostatin A (TSA) [10]. The same study de-
monstrated that HDAC3 translocated to the nucleus in
concert with H4 deacetylation during RGC death [10].
These results suggested a potential role for HDAC3 in
early RGC gene downregulation and global deacetylation
events in RGC death following axonal injury. Other
studies have also reported that HDAC3 is toxic to
differentiated neurons, indicating an important role for
HDAC3 molecular events in neurodegeneration [28,31,32].
Here we show that conditional knock out of Hdac3 in
RGCs ameliorates global deacetylation and heterochro-
matin formation, while improving nuclear integrity and
RGC viability following ONC. Interestingly, conditional
knockout of Hdac3 does not prevent the downregulation
of RGC-specific gene expression, even though TSA does.
We interpret these data as indicating that a different
class I HDAC may be responsible for global tran-
scriptional regulation in the early stage of nuclear atro-
phy. Overall, the results indicate an important role for
HDAC3 in the early events of neuronal intrinsic apop-
tosis and provide direction for dissecting the roles of
other class I HDACs in the process of early transcrip-
tional silencing during the RGC apoptotic program.
Results
Intravitreal AAV2-Cre/GFP injection transduces ganglion
cell layer of mouse retina
To selectively ablate Hdac3 in RGCs, we transduced
them with replication deficient AAV2 virus carrying a
CRE expression cassette (AAV2-Cre/GFP). AAV2 hasbeen reported to have selective tropism for RGCs [33].
To validate transduction of RGCs, we intravitreally
injected C57BL/6-Rosa26fl/fl mice containing either the
LacZ or Tomato reporter gene and monitored reporter
gene expression at times between 2 and 8 weeks of injec-
tion. In mice containing the Tomato reporter gene, fluor-
escence microscopy indicated that transduction of the
ganglion cell layer plateaued by 4 weeks post intravitreal
injection of AAV2-Cre/GFP (Additional file 1: Figure S1).
It was also found that administration of 109 genome
copies of AAV2-Cre/GFP was sufficient to achieve max-
imal transduction in the retina. In mice containing the
LacZ reporter, X-Gal staining revealed that reporter gene
expression occurred in the ganglion cell layer (GCL) after
intravitreal injection of AAV2-Cre/GFP (Figure 1A-C).
We detected AAV2-Cre/GFP transduction of cells present
in the GCL; predominantly, in BRN3A labeled RGCs as
shown by fluorescent microscopy of injected Rosa26-
Tomatofl/fl mouse eyes (Figure 1D-E). The AAV2-Cre/
GFP virus also transduced the occasional Müller cell (data
not shown). No photoreceptors, or other neurons in the
inner nuclear layer, were positively labeled for TOMATO
or GFP.
Knockdown of Hdac3 expression after intravitreal
injection of AAV2-Cre/GFP
A previous study indicated that HDAC3 was recruited to
the nuclei of RGCs following ONC, and that the mRNA
abundance of both Hdac2 and Hdac3 increased at 1 and
3 days post ONC [10]. Here, we used fluorescence micros-
copy to monitor the expression of HDAC3 protein in cells
of the GCL of Hdac3fl/fl compared to Rosa26-LacZfl/fl mice,
5 days post ONC. Fluorescence microscopy images of
retinal sections demonstrated that both Rosa26-LacZfl/fl
and Hdac3fl/fl mouse RGCs exhibited nuclear localization
of HDAC2 (Figure 2A, B). Nuclear staining for HDAC3
was detected in the Rosa26-LacZfl/fl (Figure 2C), but absent
in Hdac3fl/fl mouse RGCs (Figure 2D). Quantitative mea-
surements of the Hdac3 mRNA also showed ~72% de-
crease in total retinal mRNA levels (Figure 2E, *P ≤ 0.05),
while Western blotting for protein levels from individual
retinas showed that 5/6 mice had reduced levels of
HDAC3 in the injected eye (Figure 2F). Collectively,
however, the overall levels of HDAC3 were not statistically
significant. This discrepancy in mRNA and protein
abundance may be due to the higher sensitivity of
qPCR in comparison to Western blotting, or reflect
differences in mRNA and protein stability in INL cells,
which also express Hdac3. It was also found that
HDAC3 protein levels increase ~350% by 5 days after
ONC in Rosa26-LacZfl/fl mice, consistent with previous
reports of increased amounts of Hdac3 mRNA. Abla-
tion of Hdac3 in RGCs abrogates this damage-induced
increase (Figure 2G, *P ≤ 0.05).
Figure 1 AAV2-Cre/GFP transduces RGCs in Rosa26-LacZfl/fl and Rosa26-Tomatofl/fl mice. (A-B) Retinal whole mounts from non-injected
(A) and injected (B) eyes of Rosa26-LacZfl/fl mice were taken 8 weeks following injection. X-Gal staining indicates global reporter gene expression
in injected eyes. (C) Retinal section taken from an injected eye of Rosa26-LacZfl/fl illustrates that X-Gal staining is restricted to cells of the ganglion
cell layer (GCL) (Scale bar: 20 μm) and is not present in the outer nuclear layer (ONL) and inner nuclear layer (INL). (D) GFP fluorescence carried
by AAV2-Cre/GFP is found in the RGC somas and axons (indicated by arrows) in a retinal whole mount (Scale bar: 10 μm). (E) AAV2-Cre/GFP
tropism to RGCs in the GCL, and not to the inner plexiform layer (IPL) is shown by nuclear BRN3A (green), TOMATO (red), and DAPI (blue) co-labeling
in a retinal section (arrowhead). (Scale bar: 4 μm).
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following RGC injury
Previously, it was shown that deacetylation of histone
H4 occurred early in the apoptotic cascade initiated in
RGCs as a result of ONC [8,10]. Deacetylation was ini-
tiated within 24 hours following optic nerve damage,
and peaked by 5 days. During the second and third days
of this interval, HDAC3 was found localized to the
nuclei of dying cells [10]. To investigate the specific role
of HDAC3 in the process of H4 deacetylation, fluores-
cence microscopy was utilized to observe antibody stain-
ing of acetylated histone H4 (AcH4) in GCL nuclei at
5 days post ONC in Hdac3 +/+ and Hdac3 cKO mouse
eyes (Figure 3A-E). Results from GCL cell counts
indicated that Hdac3 cKO retinas retained comparable
numbers of AcH4-positive nuclei in the GCL to that of
untreated control retinas (P > 0.05). However, Rosa26-
LacZfl/fl retinas that underwent ONC, exhibited a sig-
nificant decrease of ~40% of positively labeled cells in
the GCL (*P ≤ 0.05) (Figure 3F). This most likely repre-
sented loss of AcH4 in the nuclei of RGCs present in
the GCL since RGCs make up ~50% of the population
of neurons in this layer [34].Hdac3 cKO blocks heterochromatin formation, nuclear
envelope breakdown, and nuclear pore damage in RGCs
following ONC
In addition to maximal histone deacetylation, 5 days after
optic nerve crush also marks the point at which a sig-
nificant number of affected cells exhibit the formation of
heterochromatin [8]. To evaluate if HDAC3-mediated his-
tone deacetylation correlates with heterochromatin forma-
tion at 5 days following ONC, cells in the GCL from
Rosa26-Tomatofl/fl and Hdac3fl/fl retinal sections were
scored on a scale of 1–3 based on images from bright field
microscopy (Figure 4). Cells in the GCL from Rosa26-
Tomatofl/fl retinas scored significantly higher than in
Hdac3fl/fl retinas for fragmented and pyknotic nuclei
(*P ≤ 0.05). To determine if the formation of pyknotic
nuclei was restricted to RGCs, we also examined nuclear
morphology of retinal whole mounts stained with DAPI
and counter-stained with the TUJ-1 antibody, which has
been reported to preferentially stain tubulin-rich RGCs
[35]. Figure 5 shows that fragmented and pyknotic nuclei
were significantly more numerous in Rosa26-Tomatofl/fl
mice after ONC (*P ≤ 0.05), while levels remained at con-
trol retina levels in Hdac3fl/fl mice. Nuclear morphology in
Figure 2 Intravitreal AAV2-Cre/GFP injection achieved conditional knockout of the Hdac3 gene. (A-B) TEXAS RED labeling of HDAC2 in
Rosa26-LacZfl/fl and Hdac3fl/fl AAV2-Cre/GFP injected eyes at 5 days post ONC illustrates nuclear localization of this HDAC in cells of the GCL of
both retinas. (C-D) TEXAS RED labeling of HDAC3 in Rosa26-LacZfl/fl and Hdac3fl/fl AAV2-Cre/GFP injected eyes at 5 days post ONC demonstrates
the lack of HDAC3 in the Hdac3fl/fl RGCs (Scale bar: 15 μm). (E) QPCR was used to determine abundance of Hdac3 mRNA from pooled retinas
of 5 Rosa26-LacZfl/fl and Hdac3fl/fl mice at 4 weeks following AAV2-Cre/GFP injection. In uncrushed retinas, the abundance of Hdac3 mRNA was
significantly lower in Hdac3 cKO retinas compared to Rosa26-LacZfl/fl retinas (*P≤ 0.05). (F) Protein from individual retinas of AAV2-Cre/GFP injected
(4-week incubation) and uninjected Hdac3fl/fl mice showed an overall decrease in protein levels in Hdac3 cKO mice, although there was no significant
difference in mean abundance (P > 0.05). (G) Pooled retinal protein from 5 AAV2-Cre/GFP injected Rosa26-LacZfl/fl and Hdac3fl/fl mice at 1 and 5 days
post ONC were run on a Western blot. ONC results in an increase in HDAC3 accumulation in Rosa26-LacZfl/fl mice by 5 days, but this response is
significantly abrogated in Hdac3fl/fl animals (*P≤ 0.05) when comparing Rosa26-LacZfl/fl and Hdac3fl/fl mice at 5 days.
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affected by Hdac3 cKO or ONC (data not shown).
Transmission electron microscopy (TEM) was also used
to visualize heterochromatin formation in GCL cells 5 days
post ONC in AAV2-Cre/GFP injected Hdac3fl/fl and
Rosa26-Tomatofl/fl mice. TEM results demonstrated a
higher incidence of early-apoptotic heterochromatic cells
in the ONC Rosa26-Tomatofl/fl retinas in comparison to
the ONC Hdac3fl/fl retinas (Figure 6A-D). These results
suggest that HDAC3 plays an important role in hetero-
chromatin formation in RGCs following axonal injury
from ONC.
During the late stages of apoptosis, the nuclei of dying
cells undergo nuclear envelope degradation and loss of
nuclear pore integrity as a result of caspase-mediated
lamin degradation. High magnification TEM imaging ofnuclear envelopes revealed heterochromatin deposition
adjacent to the inner surface of the inner membrane of
cells in Rosa26-Tomatofl/fl mice. The perinuclear space
between the inner and outer membranes also appeared
expanded (Figure 7B). Nuclear envelope structure in
Hdac3fl/fl mice exhibited minimal deposition of hetero-
chromatin and normal appearing pore structures. The
inner and outer membranes, however, often appeared
separated and wavy (Figure 7C).
Gene silencing is not affected by Hdac3 cKO retinas in
RGCs post ONC
Previously, we found that the use of the broad-spectrum
HDAC inhibitor, TSA, was effective in ameliorating RGC-
specific Fem1c gene downregulation following ONC when
administered intraperitoneally 24 hours prior to surgery
Figure 3 Hdac3 cKO ameliorated global deacetylation following RGC injury. (A-C) Retinal whole mounts were stained for AcH4 (red) in
Rosa26-LacZfl/fl and Hdac3fl/fl AAV2-Cre/GFP injected and uninjected eyes at 5 days following optic nerve crush. The control retina was an uninjected
and uncrushed Hdac3fl/fl retina, which exhibited widespread AcH4 labeling (Scale bar: 10 μm). Nuclei absent of AcH4 staining were present only in the
Rosa26-LacZfl/fl retina after ONC. (D-E) Fluorescent microscopy of the retinal sections showed that the Hdac3 cKO GCL retained visibly more AcH4
labeled cells than the Rosa26-LacZfl/fl GCL (Scale bar: 15 μm). (F) Cell counts in the GCL indicated Hdac3 cKO retinas at 5 days post ONC, retained AcH4
levels comparable to control retinas (P > 0.05), while Rosa26-LacZfl/fl retinas exhibited about a 40% decrease in AcH4 labeled cells in the GCL compared
to control retinas (*P≤ 0.05).
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sponse in dying RGCs, we quantified mRNA transcript
levels in retinas from AAV2-Cre/GFP intravitreally
injected Rosa26-Tomatofl/fl and Hdac3fl/fl mice at 5 days
post ONC. RGC specific genes of interest included Thy1,
Sncg, Nrn1, Fem1c, and Nfl. The abundance of these
mRNAs was lower in the ONC retinas than in the unila-
teral uncrushed control eyes in both the AAV2-Cre/GFP
injected Rosa26-Tomatofl/fl and Hdac3fl/fl mice (Figure 8).
As a positive control, mRNA abundance was also quanti-
fied after pre-administration of TSA. Intraperitoneal injec-
tion of TSA, 24 hours prior to ONC, was able to attenuate
the decrease in RGC-specific mRNA abundance when
compared to uninjected and DMSO injected controls
(*P ≤ 0.05). These results indicate that HDAC3 does not
specifically regulate gene silencing following acute injury
to RGCs, and they suggest that a different HDAC plays
this role.RGC apoptotic death is attenuated in Hdac3 cKO retinas
post ONC
Previous studies have shown that broad-spectrum HDAC
inhibitors such as TSA and valproic acid (VPA) prevent
RGC degeneration in models of retinal ischemic injury
and optic nerve crush [10,30,36-38]. Others have shown
that inhibition of HDAC1 and HDAC3 lead to RGC pro-
tection after neuronal injury [39]. HDAC3 has also been
shown to be toxic to neurons in vitro [28,39], and in
models of degenerative disease such as Huntington’s dis-
ease, spinocerebellar ataxia type 7, and Friedrich’s ataxia
[31,40,41]. Here, we assessed the effect of knockout of
Hdac3 on RGC cell survival after ONC. Cell counts in the
GCL indicated that at 2 weeks following ONC, Hdac3
cKO retinas had similar numbers (P > 0.05) of cells in the
GCL when compared to its contralateral non-injected and
uncrushed eye (Figure 9A). Conversely, injected Rosa26-
Tomatofl/fl retinas that underwent crush lost a significant
Figure 4 Rosa26-Tomatofl/fl retinas exhibited significantly more pyknotic nuclei at 5 days following ONC when compared to Hdac3fl/fl
cKO and control retinas. (A) A section of the retina from a Rosa26-Tomatofl/fl mouse, 5 days after ONC, to show an exemplar of the heterochromatin
scoring system. (B) Scoring data from masked observers is depicted by a bar graph. Significantly more heterochromatic and pyknotic nuclei were
detected in Rosa26-Tomatofl/fl control crushed retinas when compared to uncrushed and Hdac3 cKO crushed retinas (*P < 0.05). Heterochromatin score
of 1 = healthy cell with euchromatic nucleus and well-formed nucleolus, 2 = cell with partial apoptotic heterochromatin formation, and 3 = cell with
completely heterochromatic (pyknotic) fragmented nuclei. (Scale bar: 10 μm).
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which was comparable to the rate of cell loss in non-
injected Hdac3fl/fl and Rosa26-Tomatofl/fl mice after ONC
(data not shown). At 4 and 8 weeks post ONC, RGC num-
bers were significantly decreased (~20%) in the Hdac3
cKO retinas in comparison to contralateral control retinas
(**P ≤ 0.05), but this was still significantly less cell loss
compared to Rosa26-LacZfl/fl retinas at all time points ex-
amined following ONC (*P ≤ 0.05) (Figure 9A). These re-
sults were similar to previous work that showed RGC
protection by TSA treatment [16], indicating a critical role
for HDACs, and especially HDAC3, in the process of
RGC death.
Previous work has indicated that caspase activation oc-
curs at 3–5 days following RGC axonal injury [42].
Therefore, to determine whether Hdac3 cKO would
ameliorate downstream apoptotic caspase activation,
retinas from Hdac3fl/fl and Rosa26-Tomatofl/fl injectedmouse eyes were stained with antibody to activated
CASPASE-3 at 5 days post ONC. It was illustrated that
retinas with cKO of Hdac3 had significantly fewer posi-
tively labeled cells for activated CASPASE-3 in comparison
to Rosa26-Tomatofl/fl retinas (*P ≤ 0.05) (Figure 9B-D).
These results suggest that early apoptotic events mediated
by HDAC3 activity might be necessary for initiating the
activation of downstream events in the apoptotic pathway.
Discussion
The time course of RGC apoptosis can be temporally
divided into phases of early cell and nuclear atrophy,
initiation of BAX oligomerization, and late caspase and
endonuclease activation leading to nuclear fragmenta-
tion. The main characteristics of the events of nuclear
atrophy include gene silencing, global deacetylation,
heterochromatin formation, and a decrease in nuclear
structural integrity. Based on previous work showing
Figure 5 Hdac3 cKO prevented apoptotic heterochromatin formation in TUJ-1 positive cells in the GCL 5 days post ONC. (A-C) The
GCL of whole mounts from a Rosa26-LacZfl/fl control eye, a Rosa26-LacZfl/fl crushed eye, and an Hdac3fl/fl crushed eye stained with the TUJ-1
monoclonal antibody. Nuclear morphology was stained using DAPI. The DAPI staining of a representative cells is shown in the inset in the lower
right corner of each panel. Nuclei of TUJ-1 positive cells in control (A) and Hdac3fl/fl crushed retinas (B) typically exhibited a normal appearance
with minimal heterochromatin and a prominent nucleolus. (C) In Rosa26-LacZfl/fl retinas after ONC, however, some nuclei clearly showed
condensed staining and were fragmented. (D) Graphical representation of cell counts indicating a significantly higher percentage of TUJ-1
positive apoptotic cells in Rosa26-LacZfl/fl crushed eyes when compared to crushed Hdac3 cKO and control eyes (*P≤ 0.001). (Scale bars: 10 μm).
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with HDAC1 and HDAC3 inhibitors, and HDAC3
localization to the nuclei of RGCs prior to maximal his-
tone H4 deacetylation during apoptosis [10,28,39], we
sought to determine the role of HDAC3 in early RGC
nuclear atrophy by analyzing each of the atrophic char-
acteristics following ONC.
Here, we demonstrated that H4 deacetylation and het-
erochromatin formation were prevented in RGCs of
Hdac3 cKO retinas at 5 days following ONC. Although
nucleoli and nuclear pores remained normal appearing,
we found that the RGCs of Hdac3 cKO retinas had
wavy-appearing nuclear envelopes, which may reflect
an intermediate stage of perinuclear swelling that waspresent in the nuclei of cells of crushed control mice.
Alternatively, HDAC3 may play a role in maintaining
the latticework that supports the inner nuclear mem-
brane [43], by associating with lamin A/C (see below).
HDAC3 enzymatic activity, resulting in histone deace-
tylation and heterochromatin formation, are temporally
situated early in the apoptotic program, because they
still occur in Bax- deficient mice, where completion of
apoptosis is effectively permanently blocked [8,44]. It is
not known, however, if these HDAC3-mediated changes
are essential to activate further downstream events in
the apoptotic pathway, such as caspase activation and
nuclear fragmentation. Our results showing a correlation
between HDAC3 activity and CASPASE-3 activation
Figure 6 Hdac3 cKO blocked heterochromatin formation in the GCL 5 days following ONC. (A-B) TEM images of cells in the GCL of a
Rosa26-Tomatofl/fl control eye and AAV2-Cre/GFP injected eye, 5 days after ONC. Prominent heterochromatin formation is evident in the GCL of
Rosa26-Tomatofl/fl crushed retinas. (C-D) TEM images of cells in the GCL of an Hdac3fl/fl control eye and Hdac3 cKO crushed eye indicate no
heterochromatin formation in the GCL as a result of ONC. Nuclei with characteristics of the morphological scores described in Figure 4 are
indicated. N = nucleus, n = nucleolus, ne = nuclear envelope, and m =Müller endfoot. (Scale bar: 3 μm).
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early events and later stages in the apoptotic pathway.
Whether or not this relationship is linked to chromatin
remodeling is not known at this time. HDAC3 may also
play a role in modifying non-histone targets early in the
apoptotic process. One such target may be the transcrip-
tion factor p53. Acetylation and phosphorylation play a
critical role in regulating p53 activity by altering cellular
localization or binding affinity to specific targets [45].
Specifically, Chao and colleagues observed that HDACs
could activate p53 by deacetylating lysine residue 317,
leading to activation of pro-apoptotic gene expression
such as Bbc3 (PUMA) and Bim [46]. Both of these BH3-
only containing proteins of the Bcl2 family of genes
function by modulating the activity of BAX to promote
mitochondrial permeability leading to the release of
cytochrome-c and the activation of the caspase cascade.
Importantly, both of these proteins have been strongly
implicated in regulating RGC apoptosis after optic nerve
damage [42]. Separately, Brochier et al. [47] observed
that inhibition of p53 DNA-binding and transcriptional
activity in neurons was obtained by acetylation on ly-
sines 381 and 382. The same post-translational modifica-
tions enhance p53 activity in cancer cells, however. If
HDAC3 plays such a role in regulating the acetylation
status of p53, this would provide a mechanism for theselective toxicity of this HDAC in differentiated neurons
[28,40,48].
One of the events in nuclear atrophy not affected by
Hdac3 deletion is the silencing of normal RGC gene ex-
pression. Previously, we showed that injection of broad-
spectrum HDAC inhibitor, TSA, prior to ONC prevented
silencing of the RGC specific gene promoter, Fem1c, in
both acute and chronic (glaucomatous) models of axonal
injury [10,16]. We hypothesized that amelioration of gene
silencing would occur with the conditional knockout of
Hdac3 in RGCs of mice that later underwent ONC. How-
ever, knockout of Hdac3 did not lead to protection from
gene silencing at 5 days following ONC, rather RGC spe-
cific gene transcript abundance also decreased similar to
the change exhibited by wild type retinas. Conversely,
TSA administration prior to ONC led to significant ame-
lioration of RGC specific gene silencing in RGCs. These
results, taken together with evidence that HDACs 1, 2, 3,
and 6 localized in the retina [30], indicated a potential role
for these other HDACs in the early event of gene silencing
during RGC atrophy.
Several class I HDACs have been implicated in regu-
lating gene transcription. An appropriate candidate for in-
vestigation may be HDAC2 due to it’s increased mRNA
abundance in retinas at 1 day following ONC [10].
Previous work demonstrated that HDAC2 comprised
Figure 7 Hdac3 cKO in the RGCs prevented the breakdown of the nuclear envelope and pore integrity following ONC. (A-C) TEM
images were taken of nuclear envelopes from Hdac3fl/fl control retinas, Rosa26-Tomatofl/fl crushed retinas, and Hdac3fl/fl crushed retinas. The
nuclear lamina is situated at the top of each micrograph. (A) Example of the well-defined inner and outer membranes of the nuclear envelope
and normal pore structure of a healthy cell. (B) Example of the nuclear envelope from a cell in a Rosa26-Tomatofl/fl retina 5 days after ONC. The
nucleus exhibits formation of electron-dense heterochromatin localized to the inner surface of the nuclear envelope, and the intermembrane
space has expanded. (C) The nuclear envelope of a presumptive RGC in an Hdac3fl/fl cKO mouse after ONC. The chromatin appears euchromatic
and the nuclear envelop exhibits pore structures, although the apposition of the inner and outer membranes appears wavy. Arrowheads = nuclear
pores, small arrows = nuclear envelope double membranes (ne), N = nucleus, and hc = heterochromatin. (Scale bar: 300 nm).
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mouse retina and that retinas lacking HDAC2 underwent
less retinal degeneration following ischemic insult [30].
The HDAC1/HDAC2 corepressor complex can be tar-
geted to genes by transcription factors such as Sp1 and
Sp3, playing a role in regulation of gene expression via
chromatin remodeling [49].
A different mechanism of gene silencing, involving
lamin-associated domains, was recently demonstrated in
Drosophila S2 somatic cells, which exhibit silencing of a
multi-genic testes gene cluster. This gene cluster is se-
questered at the nuclear envelope as heterochromatin
that interacts with the lamin protein complex. Domains,
such as this one, are maintained by the activity of the
Drosophila HDAC1 homolog, with the HDAC3 homologplaying an apparent auxiliary role [43]. Lamin-associated
domains are increasingly recognized as a mechanism for
repressing gene activity during development [50]. This
phenomenon offers an interesting mechanism for gene
silencing during cell death, and is consistent with one of
the hallmarks of apoptosis, which is an initial accumula-
tion of heterochromatin along the inner surface of the
nuclear envelope [51,52]. It is unknown if this accumula-
tion of heterochromatin associates with lamin domains,
or selectively involves aggregation of genomic DNA with
actively transcribed genes that are targeted for silencing.
This potential model warrants further investigation.
Although HDAC3, by itself, evidently does not seem
to play a large role in early gene silencing, it may be a
valuable molecular target for drug inhibitor therapy
Figure 8 Gene silencing was not regulated by HDAC3 in RGCs post ONC. AAV2-Cre/GFP was injected intravitreally into Rosa26-Tomatofl/fl
and Hdac3fl/fl eyes 4 weeks prior to ONC. Additional mice were injected intraperitoneally with either DMSO or TSA, 24 hours prior to ONC.
Changes in gene expression for each group of treated mice were compared to mice that had received no injection of AAV2-Cre/GFP or HDAC
inhibitor (no injection group). Transcript abundance of ganglion cell genes Thy1, Sncg, Nrn1, Fem1c, and Nfl, measured by qPCR, showed marked
decreases in non-injected and DMSO injected as well as AAV2-Cre/GFP injected Rosa26-Tomatofl/fl and Hdac3fl/fl retinas at 5 days following ONC.
No significant difference was observed among the change in transcript abundance between Hdac3 cKO and the Rosa26-Tomatofl/fl mice in
this study (P ≥ 0.05). However, mice injected intraperitoneally with TSA 24 hours prior to ONC exhibited significantly higher levels of mRNA
abundance (*P ≤ 0.05) of RGC specific genes at 5 days following ONC when compared to uninjected and DMSO injected mice.
Figure 9 RGC death was ameliorated in Hdac3 cKO retinas at 2 weeks but not at 4 and 8 weeks following ONC. (A) Hdac3fl/fl mice
injected with AAV2-Cre/GFP retained a significantly higher percentage of the RGCs by 2, 4, and 8 weeks post ONC in comparison to injected
Rosa26-Tomatofl/fl mice (*P≤ 0.05). Retinas from Hdac3fl/fl mice injected with AAV2-Cre/GFP showed no significant cell loss at 2 weeks compared
to contralateral eyes (P > 0.05), but did exhibit cell loss by 4 and 8 weeks post ONC (**P ≤ 0.05). (B) Hdac3fl/fl mice injected with AAV2-Cre/GFP
also exhibited lower total numbers of CASPASE-3 positive cells 5 days following ONC in comparison to Rosa26-LacZfl/fl injected and crushed
retinas (*P≤ 0.05). (C-D) Examples of CASPASE-3 positive cells in (C) Rosa26-LacZfl/fl and (D) Hdac3fl/fl mice at 5 days post ONC. Images like these
were used to collect the data graphed in (B). (Scale bar: 10 μm).
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halt the progression of histone deacetylation and attenuate
subsequent RGC death after axonal injury. An important
consideration resulting from these experiments is that
HDAC-mediated changes in RGCs can be segregated into
very early events, likely associated with gene-silencing,
and later events, associated with global chromatin remo-
deling. It is still relevant to address the mechanism of gene
silencing, since RGC function is expected to rely on these
cells having a normal profile of gene expression that de-
fines cell identity and function. We anticipate that selec-
tive targeting of HDAC3 for protective therapy may yield
living, but non-functional RGCs, because of their inability
to express a genetic profile that identifies them as ganglion
cells. Further investigation into functions and timing of
different HDAC activities during the process of chromatin
remodeling will provide insight into early epigenetic
events that play a role in RGC apoptosis associated with
optic neuropathies.
Conclusions
HDAC3 was found to play a major role in global deace-
tylation of histone H4, heterochromatin formation, and
eventual cell death in RGCs that underwent axonal
injury. However, deletion of HDAC3 did not affect gene
silencing, even though the broad spectrum HDAC in-
hibitor was effective. This implies that other HDACs
commonly found in the retina also play a role in early
nuclear atrophic events during the intrinsic apoptotic
program in RGCs.
Methods
Experimental animals, AAV2-Cre/GFP injection, and ONC
All mice were handled in accordance with the Association
for Research in Vision and Ophthalmology statement for
the use of animals for research, and experimental pro-
tocols were approved by the Institutional Animal Care
and Use Committee of the University of Wisconsin. A
random mixture of male and female C57BL/6 mice bet-
ween the ages of 4–6 months, were used for experiments.
The Rosa26-LacZfl/fl mice were generously provided by
Dr. Jing Zhang from the University of Wisconsin-Madison
McArdle Laboratory for Cancer Research (Madison,
Wisconsin). Rosa26-Tomatofl/fl mice were obtained from
the Jackson Laboratory (Bar Harbor, Maine), and Hdac3fl/fl
mice [53] were obtained from Dr. Scott Hiebert at
Vanderbilt University (Nashville, Tennessee, USA). The
Rosa26 mice contain the loxP flanked PGK-Neo stop tran-
script found upstream of either Tomato or LacZ (βGEO)
reporter transcript and were used to monitor for RGC
transduction of the AAV2-Cre/GFP virus as well as
Hdac3+/+ controls for viral injections (see below). Each
treatment group contained at least 4 mice for all ex-
periments except for heterochromatin formation analysis(n = 3). The C57BL/6 Hdac3fl/fl mice contain loxP sites
flanking exon 7 of the Hdac3 gene transcript [53].
Injections of 1 μL AAV2-Cre/GFP (equaling a total of
109 gc) were administered intravitreally 4 weeks prior to
ONC. The 4-week time point was chosen after testing
transduction efficiency at 1, 2, 4, and 8 weeks post AAV2-
Cre/GFP injection showed optimal expression of Tomato
starting at 4 weeks (Additional file 1: Figure S1). AAV2-
Cre/GFP was obtained from Vector Biolabs (Philadelphia,
PA, USA), and 1:10 dilution of stock AAV2-Cre/GFP was
made in 5% glycerol in sterile phosphate buffered saline
(PBS, 137 mM NaCl, 1.8 mM KH2PO4, and 10 mM
Na2HPO4, pH 7.5) prior to injection. Intravitreal injections
were conducted using a 10 μL Hamilton syringe with a
35G needle attached. A volume of 1 μL of diluted AAV2-
Cre/GFP was injected over a period of 40 seconds, and
the needle was held in the eye for at least 30 seconds be-
fore it was retracted. ONC was performed unilaterally
using self-closing forceps to initiate degeneration of RGCs.
Retinas were harvested at 5, 14, 28, and 56 days following
ONC for analysis. Previously, we observed peak histone
H4 deacetylation in the GCL by 5 days post-ONC [10].
Therefore, retinas were harvested at 5 days to assess
mRNA abundance, histone H4 deacetylation, and hetero-
chromatin formation. Retinas were collected at 14, 28, and
56 days post ONC for cell counts. Cell counts were ob-
tained using a modification of the method described in Li
et al. (2007) [54]. Briefly, digital images collected at 400×
magnification were taken of each lobe of a retinal whole
mount stained with DAPI. Cell numbers were determined
in 24 separate 100 μm2 fields for each retina. Change in
cell number for each experimental eye was calculated as a
percentage of cell numbers in the corresponding control
eye of each mouse.
β-galactosidase staining and bright field microscopy
β-galactosidase reporter expression was identified his-
tochemically in retinal sections and whole mounts by
X-Gal assay. X-gal staining solution was prepared ahead
of time in the dark by adding N, N dimethylformamide
to X-gal (0.02% Igepal, 0.01% sodium deoxycholate,
5 mM potassium ferricyanide, 5 mM potassium fer-
rocyanide, and 2 mM MgCl2 diluted in 0.1 M PBS
[pH 7.3]). Mice were euthanized and eyes were collected
and fixed in 4% paraformaldehyde in PBS at room
temperature for 50 minutes. For whole mounts, the eye
was then rinsed with PBS, and the anterior portion of
the eye was removed, leaving an eyecup. The eyecup was
then washed in PBS containing 2 mM MgCl2 and 2 μM
CaCl2 and stained by incubation in staining solution
containing 1 mg/mL X-gal at 37°C for 18 hours. After
staining, the retina was dissected from the eyecup and
whole mounted on glass slides. For sections, the eye was
rinsed with PBS, and the anterior portion of the eye was
Table 1 Primers for qPCR analysis











All primers were designed to span at least one intron. For each gene, the
forward primer is shown first.
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brated in 30% sucrose overnight at 4°C before mounting
in blocks of Tissue-Tek O.C.T. Compound from Fisher
Scientific (Pittsburgh, PA) for cryosectioning (5 μm thick).
Sections were then rinsed in PBS containing 2 mM MgCl2
and 2 μM CaCl2 and stained by incubation in staining
solution containing 1 mg/mL X-gal at 37°C for 18 hours.
Retinas were then washed in PBS and stained with nuclear
fast red stain for 5 minutes. The slides were examined and
photographed using an Olympus BX40 light microscope
(Olympus America Inc., Center Valley, PA) and digital
camera attachment.
Immunofluorescence
Indirect immunofluorescence on 5 μm thick frozen re-
tinal sections and whole mounts was done as described
previously [10]. Cryosections and whole mounts were
mounted on Superfrost Plus microscope slides (Fisher
Scientific) and rinsed in PBS. The sections were then
blocked in 5% bovine serum albumin (BSA) in PBS for
3 hours at room temperature and later rinsed in PBS.
Primary antibodies including polyclonal rabbit antibody
to human HDAC3 (#sc-11417) and polyclonal rabbit
antibody HDAC2 (#sc-7899) (both from Santa Cruz,
Dallas, TX), polyclonal rabbit antibody to human AcH4
(#06-866) and monoclonal mouse primary to human
BRN3A (#MAB1585) (both from EMD Millipore Inc.,
Billerica, MA), monoclonal mouse primary to human
TUJ-1 (#ab14545) (AbCam, Cambridge, MA), and poly-
clonal rabbit primary antibody to human CASPASE-3
(#AF835) (R&D Systems, Minneapolis, MN) were used
at 1:100 dilutions. Sections and whole mounts were in-
cubated in primary antibody for 24–48 hours at 4°C and
washed in PBS afterwards. Secondary antibodies used in-
cluded goat anti-rabbit TEXAS RED (1:1,000) and goat
anti-mouse FITC (1:1,000) (Jackson ImmunoResearch
Laboratories, West Grove, PA). Sections and whole
mounts were incubated in secondary antibody at room
temperature in the dark for 2 hours and washed in PBS.
All sections and whole mounts were counter-stained for
10 minutes with 4’, 6-diamidino-2-phenylindole (DAPI)
and were washed in PBS. Finally, sections and whole
mounts were mounted using Immumount mounting
medium (Fisher Scientific) and coverslipped. Fluorescent
images were obtained using a Zeiss Axioplan 2 Imaging
microscope with Axiovision 4.6.3.0 software (Carl Zeiss
MicroImaging Inc., Thornwood, NY).
Transmission Electron Microscopy (TEM)
Rosa26-Tomatofl/fl and Hdac3fl/fl mouse eyes were in-
jected with AAV2-Cre/GFP and after 4 weeks were sub-
jected to ONC surgery. Animals were analyzed 5 days
after ONC surgery. Enucleated eyes were immersed in
4% paraformaldehyde in 0.1 M Phosphate buffer (PB) for5 minutes, after which the anterior chambers and lenses
were dissected away from each eyecup. A small region
of the superior eyecup was then removed and placed in
2.5% glutaraldehyde, 2% paraformaldehyde in PB over-
night at 4°C. Tissues were postfixed in 1% osmium tet-
roxide in PB, dehydrated in ethanol, and embedded in
Epon epoxy. Sections (60–90 nm) were cut, stained with
50% ethanoic uranyl acetate and Reynold’s lead citrate,
and viewed using a Phillips CM120 transmission elec-
tron microscope (FEI Company, Hillsboro, OR).
Heterochromatin scoring analysis
Tissues processed for TEM were also sectioned for bright
field microscopy. Thick (1 μm) sections were cut from
epoxy embedded samples and stained with Richardson’s
stain (methylene blue and azure blue). Sections were im-
aged using an Olympus BX40 light microscope and a
digital camera attachment. Nuclear morphology of cells in
the GCL was scored by 3 masked observers. A score of 1
indicated cells that exhibited healthy euchromatic nuclei
with well-formed nucleoli; a score of 2 indicated cells that
were partially heterochromatic; and a score of 3 indicated
cells that had completely condensed pyknotic chromatin
or fragmented nuclei.
Evaluation of transcript abundance in the retina by qPCR
Total retinal RNA was isolated from 5 pooled retinas at
5 days post ONC by acid-phenol extraction, and RNA was
then DNase I treated (Promega, Madison, WI). First
strand cDNA using reverse transcriptase and oligo (dT)
was synthesized from 2 μg of isolated and purified total
RNA [55]. The resulting cDNA was diluted 10-fold and
5 μl of cDNA was used for each qPCR reaction with SYBR
Green PCR master mix (Applied Biosystems, Foster City,
CA) and the appropriate RGC gene-specific primers as
listed in the table of primer sequences (Table 1). Quan-
titative PCR was conducted on triplicate samples in each
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Biosystems). Data were obtained from triplicate samples
for each target cDNA. Absolute transcript quantification
was based on a standard S16 curve run during the same
reaction and the copy number was normalized to S16
ribosomal protein mRNA. The mRNA transcript values
are expressed as the percent change from contralateral
control eye to treatment eye. Data were reported as the
mean ± SD of these differences.
Western blot analysis
Western blot analysis was conducted on 5 pooled
Tomatofl/fl and Hdac3fl/fl mouse retinas from each treat-
ment group described. Individual retinas harvested from
Hdac3 cKO and control eyes were also analyzed. Retinal
protein was loaded in triplicate with 50 μg per lane on
12% polyacrylamide gels and transblotted onto Immobilon
P (Millipore, Inc., Billerica, MA). Membranes were probed
for HDAC3, HDAC2, and ACTIN. Rabbit polyclonal anti-
bodies were used at 1:1,000 for HDAC3 and HDAC2 and
a goat monoclonal antibody was used at 1:250 for ACTIN
(I-19) (cat# sc-1616) (Santa Cruz, CA). Firstly, the blots
were incubated in donkey anti-goat secondary (1:10,000)
conjugated to IRDye 800CW (cat# 926–32214), and after
washing in PBS, incubated in goat anti-rabbit secondary
(1:10,000) conjugated to IRDye 680RD (cat# 926–68071)
(LICOR, Lincoln, NE). Images were scanned and analyzed
using the Odyssey Clx (LICOR). Band fluorescence was
quantified using Image Studio software, and data were
normalized to the ACTIN loading control on each blot.
Statistical analysis
Data were collected from a minimum of 4 independent
samples in all experiments except for analysis of hetero-
chromatin formation (n = 3), and shown as the mean ±
standard deviation in all experiments except for cell
counts, where data was shown as the mean ± standard
error. All statistical analyses were performed using
either the Student’s t-test with statistical significance set
at P ≤ 0.05 for comparison of two groups or ANOVA
with Bonferroni adjustments with statistical significance
set at P ≤ 0.05 for comparison of multiple groups.Additional file
Additional file 1: Figure S1. Optimal viral transduction and gene
expression following intravitreal injection of AAV2-Cre/GFP. Outer
panels indicate high magnification images of cells from the ganglion
cell layer of retinal whole mounts from Rosa26-Tomatofl/fl mice
intravitreally injected with AAV2-Cre/GFP 2 and 8 weeks prior.
(Scale bar: 10 μm) The inner panels illustrate low magnification
images of whole-mounted retinas from the same Rosa26- Tomatofl/fl
mice that were intravitreally injected 1, 2, 4, and 8 weeks prior to
imaging. Expression of td-Tomato peaks as early as 4 weeks post
AAV2-Cre injection.Abbreviations
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